5/5
This work could help improve how existing GLP-1 medicines are used and guide new treatments for inflammatory diseases like arthritis and inflammatory bowel disease. 🙌
@sinaihealth.bsky.social
@sinaihealth.bsky.social5/5
This work could help improve how existing GLP-1 medicines are used and guide new treatments for inflammatory diseases like arthritis and inflammatory bowel disease. 🙌
@sinaihealth.bsky.social🔬 New in JAMA Surgery @jamasurgery.com:
Sinai Health’s Dr. Vasily Giannakeas’ latest research supports current guidance on timing of preventative ovarian surgery in BRCA1/2 carriers between ages 35 and 45 to reduce ovarian cancer risk.
Read the paper ➡️ bit.ly/4hk1Ng5
@sinaihealth.bsky.social🧬 An expert team led by Sinai Health's Dr. Jordan Lerner-Ellis has released recommendations in AJHG to align genetic data sharing across Canadian clinical labs, strengthening patient privacy and professional trust.
Read the paper ➡️ bit.ly/4hr8SeJ
@sinaihealth.bsky.social🌈 A colorful glimpse into histology staining at The Centre for Phenogenomics.
Special stains highlight tissues in different colours, revealing biological structures under the microscope.
🔬 Learn more ➡️ phenogenomics.ca
@sinaihealth.bsky.socialSinai Health’s Lunenfeld-Tanenbaum Research Institute welcomes Drs. Vasily Giannakeas and Selin Jessa as new research leaders, bringing expertise in cancer epidemiology and developmental biology.
Read more ➡️ www.sinaihealth.ca/news/meet-th...
@sinaihealth.bsky.social💊 A new Sinai Health study of 2.3M older adults identifies potentially unnecessary drug combinations that call for practice change and safeguards for patients.
Read the story ➡️ bit.ly/46PxEQN
